Literature DB >> 17497780

Acyclic ribooxacarbenium ion mimics as transition state analogues of human and malarial purine nucleoside phosphorylases.

Erika A Taylor1, Keith Clinch, Peter M Kelly, Lei Li, Gary B Evans, Peter C Tyler, Vern L Schramm.   

Abstract

Transition state analogues of PNP, the Immucillins and DADMe-Immucillins, were designed to match transition state features of bovine and human PNPs, respectively. A third generation of inhibitors has been designed that contain an acyclic iminoalcohol to replace the cyclic mimic of the ribooxacarbenium ion at the transition states of PNPs. The best third generation inhibitor is equivalent to the best inhibitors found in the previous transition state analogues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17497780     DOI: 10.1021/ja071087s

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  13 in total

1.  A direct NMR method for the measurement of competitive kinetic isotope effects.

Authors:  Jefferson Chan; Andrew R Lewis; Michel Gilbert; Marie-France Karwaski; Andrew J Bennet
Journal:  Nat Chem Biol       Date:  2010-04-25       Impact factor: 15.040

2.  Acyclic immucillin phosphonates: second-generation inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.

Authors:  Keith Z Hazleton; Meng-Chiao Ho; Maria B Cassera; Keith Clinch; Douglas R Crump; Irving Rosario; Emilio F Merino; Steve C Almo; Peter C Tyler; Vern L Schramm
Journal:  Chem Biol       Date:  2012-06-22

3.  Altered enthalpy-entropy compensation in picomolar transition state analogues of human purine nucleoside phosphorylase.

Authors:  Achelle A Edwards; Jennifer M Mason; Keith Clinch; Peter C Tyler; Gary B Evans; Vern L Schramm
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

4.  Chemical biologists gather in Heidelberg.

Authors:  Maja Köhn; Carsten Schultz
Journal:  Nat Chem Biol       Date:  2009-02       Impact factor: 15.040

5.  A beta-fluoroamine inhibitor of purine nucleoside phosphorylase.

Authors:  Jennifer M Mason; Andrew S Murkin; Lei Li; Vern L Schramm; Graeme J Gainsford; Brian W Skelton
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

Review 6.  Enzymatic transition states, transition-state analogs, dynamics, thermodynamics, and lifetimes.

Authors:  Vern L Schramm
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

7.  Modulating Enzyme Catalysis through Mutations Designed to Alter Rapid Protein Dynamics.

Authors:  Ioanna Zoi; Javier Suarez; Dimitri Antoniou; Scott A Cameron; Vern L Schramm; Steven D Schwartz
Journal:  J Am Chem Soc       Date:  2016-03-08       Impact factor: 15.419

8.  Intracellular rebinding of transition-state analogues provides extended in vivo inhibition lifetimes on human purine nucleoside phosphorylase.

Authors:  Sara T Gebre; Scott A Cameron; Lei Li; Y S Babu; Vern L Schramm
Journal:  J Biol Chem       Date:  2017-08-09       Impact factor: 5.157

9.  Third-generation immucillins: syntheses and bioactivities of acyclic immucillin inhibitors of human purine nucleoside phosphorylase.

Authors:  Keith Clinch; Gary B Evans; Richard F G Fröhlich; Richard H Furneaux; Peter M Kelly; Laurent Legentil; Andrew S Murkin; Lei Li; Vern L Schramm; Peter C Tyler; Anthony D Woolhouse
Journal:  J Med Chem       Date:  2009-02-26       Impact factor: 7.446

10.  Transition-state geometry measurements from (13)c isotope effects. The experimental transition state for the epoxidation of alkenes with oxaziridines.

Authors:  Jennifer S Hirschi; Tetsuya Takeya; Chao Hang; Daniel A Singleton
Journal:  J Am Chem Soc       Date:  2009-02-18       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.